Laboratory of Ryan Ross, PhD

The research of Ryan Ross, PhD, is in the field of skeletal biology. We are particularly interested in the role of mineralization and other bone quality factors that influence skeletal function.

Our work

Mineralization is the final step in the bone formation phase, providing the skeleton with its characteristic strength. Additionally, the mineral within the bone provides an important ion reserve to maintain the necessary calcium and phosphate for numerous biological processes. Our lab is interested in understanding the process of mineralization with the aim of improving treatments for skeletal diseases such as osteoporosis. We are also working to test novel treatment strategies for diseases of aberrant mineralization (osteomalacia).

Mineralization is controlled at the local, bone level, as well as systemically, where several organ systems influence the availability of calcium and phosphate. Recently, it has become apparent that the skeleton is not a silent player in this process and instead produces proteins with hormonal function. As our research has branched into the systemic control of mineralization, we have also become interested in the interaction between the skeleton and non-bone organs and the contributions of these interactions to health and disease.

Back to top

Technology and methods

We use a variety of methods to investigate bone quality and mineralization:

  • Micro-computed tomography
  • Mechanical testing
  • Backscattered scanning electron microscopy
  • Fourier transform infrared spectroscopy
  • Dynamic and static histomorphometry
  • Immunochemical staining
  • Cell culture of mineralizing osteoblasts
  • Animal models: surgical, non-surgical and transgenic
  • PCR, ELISA, Luminex

Back to top

Grants

  • NIH K01AR073923-01A1: “Sclerostin Regulation of Skeletal Mineralization and Phosphate Metabolism”  Principle Investigator: Ryan Ross
  • Rush University Searle Innovators Award: “Patient Intrinsic Factors Predict Peri-implant Osteolysis”  Principle Investigator: Ryan Ross
  • Orthopaedic Research and Education Foundation (OREF): “Improved Predictions of Orthopaedic Implant Fixation”  Principle Investigator: Ryan Ross
  • NIH/NIA P30AG010161-PILOT: “Bone Mineral Density as a Risk Factor for Incident Disability”  Lead principle Investigator: David Bennett, Pilot project PI: Ryan Ross
  • Women’s Interagency HIV Study (WIHS) Subcontract: “The Role of Bone-Derived Hormones in HIV-induced Aging Pathologies”  Subcontract PI: Ryan Ross

Back to top

Publications

A full list of Ryan Ross’ research publications can be found on PubMed.

Back to top

Our team

Kelsey Carpenter

I grew up in southeast Michigan and earned a Bachelor of Science in anthropology at Michigan State University. I then attended Mercyhurst University where I completed a Master of Science in biological and forensic anthropology. My graduate education in the Integrated Biomedical Sciences PhD program at Rush University began in the fall of 2017.
My dissertation research is focused on X-linked hypophosphatemia (XLH), a rare metabolic bone disease. XLH is the most common form of heritable rickets and is first diagnosed in children who present with shortened stature, leg bowing, low bone mass, and increased fracture risk. My project involves using a mouse model of XLH to investigate different treatment options for the disease. Methods used to complete this study include micro-computed tomography, ELISA, quantitative PCR, and histology. The goal of this study is to improve phosphate metabolism and skeletal mineralization, ultimately leading to improved stature, bone mass and overall quality of life for patients with XLH.

Kyle Anderson

I am particularly interested in understanding changes in bone biology in specific disease states and unique physiological environments. My work examines a wide variety of topics regarding bone alterations in: Human Immunodeficiency Virus (HIV), X-linked Hypophosphatemia (XLH), hindlimb suspension, and spaceflight related osteopenia. The studies utilize back Scatter Electron Microscopy (bSEM) and microcomputed tomography (µCT) to evaluate changes in bone quality.
The primary objective of my work is to better understand bone mineralization in these specific physiological states and how medications such as bisphosphonates as well as sclerostin-antibody (romosozumab) can better manage them.
While I was born in Chicago, I grew up in southeast Michigan and attended Michigan State University and studied human biology and philosophy. I then attended the University of Michigan for a master’s in physiology with a research focus on adrenal endocrinology. I am now happily back in Chicago as of the fall of 2016 where I began medical school at Rush Medical College.

Arnold Z. Olali

The success of antiretroviral therapy (ART) has extended the life-span of HIV infected patients to that of the general population. This increased life expectancy is accompanied by increases in a number of co-morbid conditions including osteoporosis and bone fracture. I am interested in understanding effects of HIV, HIV inflammatory mediators, and ART on bone cells and bone quality. In the proposed study we use, micro-computed tomography, ELISA, quantitative PCR, and histology as well as cell culture.
I was born in Kenya, but raised in Maryland. I attended St. Lawrence University in Canton NY where I completed by BS in Conservation Biology. I then completed a Post Baccalaureate Research Education training program in microbiology at the University of Chicago where I studied flavivirus. Now I am at Rush University Medical Center as an Integrated Biomedical Science PhD student.

Back to top

Contact

Ryan Ross, PhD
Assistant Professor
Department of Cell & Molecular Medicine
Rush University Medical Center
Armour Academic Facility
600 S Paulina St. Room 512B
Chicago, IL 60612
Phone: (312) 942-5959
Email: ryan_ross@rush.edu

Back to top